Oncology Central

Practice-changing breakthrough made for rare cancer

A novel chemotherapy strategy has improved cure rates for a rare cancer of the muscle tissue, termed rhabdomyosarcoma. The research was presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting held 1–5 June 2018 in Chicago (IL, USA).
To view restricted content, please:



News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.